Your correspondent has seen a copy of a letter from one woman's GP practice insisting that her deficiency is dietary so she was refused injections
[Google Scholar] 69.He E., Ma Y., Kong L., Huang Y., Huang C., Yang W., Zhu L
Every fat-metabolism, NAD+, SIRT1 and lean-mass effect described above is preclinical (rodent or cell) only and should be read as a hypothesis, not an established human benefit
Each drop will give about 3.3mg of the peptide
However, this disparity tends to diminish post-menopause
Specifically, research has found GHK-Cu downregulates genes involved in: Metastasis and invasion (MMP-2, MMP-9) Tumor angiogenesis (distinct from healthy tissue angiogenesis it supports) Cancer stem cell maintenance The proposed mechanism is that GHK-Cu may restore normal cellular differentiation programs that cancer cells have dysregulated